Charleston, SOUTH%20CAROLINA9 Active Studies

Ankylosing Spondylitis Clinical Trials in Charleston, SOUTH%20CAROLINA

Find 9 actively recruiting ankylosing spondylitis clinical trials in Charleston, SOUTH%20CAROLINA. Connect with local research sites and explore new treatment options.

9
Active Trials
9
Sponsors
1,760
Enrolling

Recruiting Ankylosing Spondylitis Studies in Charleston

RecruitingCharleston, SOUTH%20CAROLINANCT06824181

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether the investigational pneumococcal conjugate vaccine PCV21 is safe and can help the body to develop germ-fi...

580 participants
Sanofi
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT06257706

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Transmural healing (TMH) is recognized as a potentially important measure of Crohn's disease (CD) activity but not a formal target. Observational studies suggest that TMH may be associated with better...

304 participants
Alimentiv Inc.
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT06463587

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

The purpose of this clinical study is to determine the efficacy and safety of a new oral cladribine formulation in participants with Generalized Myasthenia Gravis (gMG) in comparison to placebo. It wi...

264 participants
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT06184750

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Increasing breast density is a well establi...

200 participants
National Cancer Institute (NCI)
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT06425549

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

The primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared to active control (ustekinumab) in children and adolescents aged 6 to \<18 years ...

168 participants
UCB Biopharma SRL
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT06408935

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic Resonance Index of Act...

112 participants
Janssen-Cilag Ltd.
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT03843463

Escitalopram and Language Intervention for Subacute Aphasia

In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming un...

88 participants
Johns Hopkins University
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT05582993

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

The main aim of the study is to evaluate the effectiveness of prophylaxis with vonicog alfa (recombinant von Willebrand factor \[rVWF\]) in children. This study will enroll those participants who have...

24 participants
Takeda
View Study Details
RecruitingCharleston, SOUTH%20CAROLINANCT06613477

PK/PD of Digoxin in Infants With SVHD

The primary participant will be an infant with single ventricle heart disease. This is a research study to learn more about how the medication digoxin, which is routinely prescribed to infants and ch...

20 participants
Duke University
View Study Details

About Ankylosing Spondylitis Clinical Trials in Charleston

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 9 ankylosing spondylitis clinical trials recruiting participants in Charleston, SOUTH%20CAROLINA. These studies are seeking a combined 1,760 participants. Research is being sponsored by Sanofi, Alimentiv Inc., Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Charleston — FAQ

Are there ankylosing spondylitis clinical trials in Charleston?

Yes, there are 9 ankylosing spondylitis clinical trials currently recruiting in Charleston, SOUTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Charleston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charleston research site will contact you about next steps.

Are clinical trials in Charleston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charleston studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 9 active trials in Charleston are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov